Future of haemophilia outcome assessment: registries are key to optimized treatment
- PMID: 27199237
- DOI: 10.1111/joim.12504
Future of haemophilia outcome assessment: registries are key to optimized treatment
Keywords: factor IX; factor VIII; haemophilia; pharmacovigilance; registries; safety surveillance.
Similar articles
-
Registry-based outcome assessment in haemophilia: a scoping study to explore the available evidence.J Intern Med. 2016 Jun;279(6):502-14. doi: 10.1111/joim.12434. Epub 2016 Mar 21. J Intern Med. 2016. PMID: 26999367 Review.
-
[Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].Ned Tijdschr Geneeskd. 1997 Dec 27;141(52):2566-71. Ned Tijdschr Geneeskd. 1997. PMID: 9555158 Review. Dutch.
-
Assessment of outcomes.Haemophilia. 2014 May;20 Suppl 4:114-20. doi: 10.1111/hae.12426. Haemophilia. 2014. PMID: 24762286 Review.
-
[Home treatment in hemophilia].Wien Klin Wochenschr. 1987 Nov 20;99(22):773-7. Wien Klin Wochenschr. 1987. PMID: 3124354 German.
-
Home treatment of haemophilia and Christmas disease: five years' experience.Br J Haematol. 1977 Sep;37(1):53-66. Br J Haematol. 1977. PMID: 588479 No abstract available.
Cited by
-
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain.Eur J Haematol. 2020 Jul;105(1):94-100. doi: 10.1111/ejh.13414. Epub 2020 Apr 16. Eur J Haematol. 2020. PMID: 32220097 Free PMC article.
-
Exploring the relationship between condition severity and health-related quality of life in people with haemophilia A across Europe: a multivariable analysis of data from the CHESS II study.Health Qual Life Outcomes. 2024 Jul 29;22(1):58. doi: 10.1186/s12955-024-02267-6. Health Qual Life Outcomes. 2024. PMID: 39075533 Free PMC article.
-
European principles of inhibitor management in patients with haemophilia.Orphanet J Rare Dis. 2018 Apr 27;13(1):66. doi: 10.1186/s13023-018-0800-z. Orphanet J Rare Dis. 2018. PMID: 29703220 Free PMC article. Review.
-
Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study.J Health Econ Outcomes Res. 2024 May 6;11(1):122-133. doi: 10.36469/001c.92369. eCollection 2024. J Health Econ Outcomes Res. 2024. PMID: 38721331 Free PMC article.
-
The cost of severe haemophilia in Europe: the CHESS study.Orphanet J Rare Dis. 2017 May 31;12(1):106. doi: 10.1186/s13023-017-0660-y. Orphanet J Rare Dis. 2017. PMID: 28569181 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical